Pediatric Pulmonology

Article	Citations
COVID‐19 and multisystem inflammatory syndrome in children: A systematic review and meta‐analysis	125
Pediatric long‐COVID: An overlooked phenomenon?	114
Cystic fibrosis patients of minority race and ethnicity less likely eligible for CFTR modulators based on CFTR genotype	106
During the COVID‐19 pandemic where has respiratory syncytial virus gone?	92
Impact of COVID‐19 social distancing on viral infection in France: A delayed outbreak of RSV	73
COVID‐19 in childhood: Transmission, clinical presentation, complications and risk factors	61
Influenza and respiratory syncytial virus during the COVID‐19 pandemic: Time for a new paradigm?	57
Increasing life expectancy in cystic fibrosis: Advances and challenges	56
Neurodevelopmental outcomes of infants with bronchopulmonary dysplasia	47
Effects of the COVID‐19 lockdown on sleep duration in children and adolescents: A survey across different continents	45
Impact of COVID‐19 outbreak in acute bronchiolitis: Lesson from a tertiary Italian Emergency Department	43
Nusinersen for spinal muscular atrophy type 1: Real‐world respiratory experience	42
Persistent pulmonary hypertension of the newborn	40
Unexpected decline in pediatric asthma morbidity during the coronavirus pandemic	39
Lung growth and pulmonary function after prematurity and bronchopulmonary dysplasia	38
Protracted respiratory findings in children post‐SARS‐CoV‐2 infection	38
Structural and functional development in airways throughout childhood: Children are not small adults	37
Review of CFTR modulators 2020	37
Bacteriophage therapy for infections in CF	37
Telemedicine in children with medical complexity on home ventilation during the COVID‐19 pandemic	36
Impact of elexacaftor–tezacaftor–ivacaftor on bacterial colonization and inflammatory responses in cystic fibrosis	36
Pediatric lung imaging features of COVID‐19: A systematic review and meta‐analysis	35
Pediatric asthma control during the COVID‐19 pandemic: A systematic review and meta‐analysis	35
Psychological interventions during COVID pandemic: Telehealth for individuals with cystic fibrosis and caregivers	34
Reduced pediatric urgent asthma utilization and exacerbations during the COVID‐19 pandemic	33

Assessment of respiratory muscles and motor function in children with SMA treated by nusinersen	32
Reduction of pulmonary exacerbations in young children with cystic fibrosis during the COVID‐19 pandemic	30
Aerosol transmission of SARS‐CoV‐2 by children and adults during the COVID‐19 pandemic	29
Oxidant and antioxidant balance in patients with COVID‐19	29
Pulmonary hypertension in the child with bronchopulmonary dysplasia	28
Pediatric P‐ANCA vasculitis following COVID‐19	28
COVID‐19 under 19: A meta‐analysis	27
Seroprevalence of anti‐SARS‐CoV‐2 IgG antibodies in children with household exposure to adults with COVID‐19: Preliminary findings	27
RSV through the COVID‐19 pandemic: Burden, shifting epidemiology, and implications for the future	26
Lung ultrasound in the diagnosis and monitoring of 30 children with coronavirus disease 2019	25
Life with pediatric home ventilation: Expectations versus experience	25
Exposure to violence, chronic stress, nasal DNA methylation, and atopic asthma in children	24
A narrative review of diaphragmatic ultrasound in pediatric critical care	24
Effects of the COVID‐19 pandemic and lockdown on symptom control in preschool children with recurrent wheezing	23
Lung ultrasound for early surfactant treatment: Development and validation of a predictive model	23
Lung ultrasound in bronchiolitis	23
Reliability of machine learning to diagnose pediatric obstructive sleep apnea: Systematic review and meta‐analysis	22
Management of neuropsychiatric symptoms in adults treated with elexacaftor/tezacaftor/ivacaftor	22
Morbidity and respiratory outcomes in infants requiring tracheostomy for severe bronchopulmonary dysplasia	22
Can lung ultrasound score accurately predict surfactant replacement? A systematic review and meta‐analysis of diagnostic test studies	22
Predictors of proper inhaler technique and asthma control in pediatric patients with asthma	21
High flow nasal cannula versus standard low flow nasal oxygen during flexible bronchoscopy in children: A randomized controlled trial	21
Bronchopulmonary dysplasia as a determinant of respiratory outcomes in adult life	21
Pediatric obstructive sleep apnea—Dental professionals can play a crucial role	21
Area deprivation and respiratory morbidities in children with bronchopulmonary dysplasia	21
The use of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis postliver transplant: A case series	21
Prediction of extubation readiness using lung ultrasound in preterm infants	20
Long‐term pulmonary sequelae in adolescents post‐SARS‐CoV‐2 infection	20
SARS‐CoV‐2 acute bronchiolitis in hospitalized children: Neither frequent nor more severe	20
Early nasal continuous positive airway pressure failure prediction in preterm infants less than 32 weeks gestational age suffering from respiratory distress syndrome	20
Characteristics of infants or children presenting to outpatient bronchopulmonary dysplasia clinics in the United States	20
Obesity‐related asthma in children: A role for vitamin D	19
Respiratory outcomes of “new” bronchopulmonary dysplasia in adolescents: A multicenter study	19
The respiratory impact of novel therapies for spinal muscular atrophy	19
Azithromycin for preventing bronchopulmonary dysplasia in preterm infants: A systematic review and meta‐analysis	19
Restless sleep disorder, restless legs syndrome, and periodic limb movement disorder—Sleep in motion!	19
Real‐time effects of COVID‐19 pandemic lockdown on pediatric respiratory patients	18
Vitamin‐D supplementation as an adjunct to standard treatment of asthma in children: A randomized controlled trial (ViDASTA Trial)	18
Outcomes of infants born during the first 9 years of CF newborn screening in the United States: A retrospective Cystic Fibrosis Foundation Patient Registry cohort study	18
The association of area deprivation and state child health with respiratory outcomes of pediatric patients with cystic fibrosis in the United States	18
Reference values for respiratory sinusoidal oscillometry in children aged 3 to 17 years	18
Frequency of asthma exacerbation in children during the coronavirus disease pandemic with strict mitigative countermeasures	18
Detection of disease‐causing CFTR variants in state newborn screening programs	18
The effect of the COVID‐19 lockdown on children with asthma‐related symptoms: A tertiary care center experience	17
Diagnostic value of lung ultrasonography in children with COVID‐19	17
Comparison of chest radiography and chest CT for evaluation of pediatric COVID‐19 pneumonia: Does CT add diagnostic value?	17
Novel imaging techniques for cystic fibrosis lung disease	17
A survey: Understanding the health and perspectives of people with CF not benefiting from CFTR modulators	17
Decannulation following tracheostomy in children: A systematic review of decannulation protocols	17
Clinical, functional, and computed tomography findings in a cohort of patients with neuroendocrine cell hyperplasia of infancy	16

Accuracy of lung and diaphragm ultrasound in predicting successful extubation in extremely preterm infants: A prospective observational study	16
Variation in cystic fibrosis newborn screening algorithms in the United States	16
Sildenafil for pulmonary hypertension in neonates: An updated systematic review and meta‐analysis	16
Tracheostomy trends in preterm infants with bronchopulmonary dysplasia in the United States: 2008–2017	16
Pierre Robin and breathing: What to do and when?	16
Impact of nonpharmacological COVID‐19 interventions in hospitalizations for childhood pneumonia in Brazil	16
Positive and negative impacts of elexacaftor/tezacaftor/ivacaftor: Healthcare providers' observations across US centers	16
CFTR modulator drug desensitization: Preserving the hope of long term improvement	16
Diagnosis, management, and outcomes of pediatric tracheostomy‐associated infections: A scoping review	16
Outcomes of infants with severe bronchopulmonary dysplasia who received tracheostomy and home ventilation	15
Outcomes of early repeat sweat testing in infants with cystic fibrosis transmembrane conductance regulator‐related metabolic syndrome/CF screen‐positive, inconclusive diagnosis	15
Secondary household transmission of SARS‐CoV‐2 among children and adolescents: Clinical and epidemiological aspects	15
Entering the era of highly effective modulator therapies	15
Elexacaftor–Tezacaftor–Ivacaftor improves exercise capacity in adolescents with cystic fibrosis	15
Chylothorax in the neonate—A stepwise approach algorithm	15
Nutrition and growth in infants with established bronchopulmonary dysplasia	14
Co‐morbid anxiety and depression in childhood asthma and its effect on symptom control: A cross sectional study	14
Central airway issues in bronchopulmonary dysplasia	14
Sleep disorders in children with asthma	14
Laboratory parameters between multisystem inflammatory syndrome in children and Kawasaki disease	14
Tracheal anomalies associated with Down syndrome: A systematic review	14
Respiratory syncytial virus and SARS‐CoV‐2 coinfections in children	14
Tracheobronchitis in children with tracheostomy tubes: Overview of a challenging problem	14
Lung ultrasound scores in neonatal clinical practice: A narrative review of the literature	14
Cerebral and splanchnic oxygenation during automated control of inspired oxygen (FiO2) in preterm infants	14
Clinical change 2 years from start of elexacaftor‐tezacaftor‐ivacaftor in severe cystic fibrosis	14
A multicenter retrospective study of clinical features, laboratory characteristics, and outcomes of 166 hospitalized children with coronavirus disease 2019 (COVID‐19): A preliminary report from Irania	14
Factors associated with complicated pneumonia in children	13
Risk factors for respiratory syncytial virus bronchiolitis hospitalizations in children with chronic diseases	13
The association of vitamin D and vitamin E levels at birth with bronchopulmonary dysplasia in preterm infants	13
Parent perspectives on facilitating decision‐making around pediatric home ventilation	13
Epidemiologic Study of Cystic Fibrosis: 25 years of observational research	13
Refinement of newborn screening for cystic fibrosis with next generation sequencing	13
Ground glass and fibrotic change in children with surfactant protein C dysfunction mutations	13
Newer bronchopulmonary dysplasia definitions and prediction of health economics impacts in very preterm infants	13
Cytokine profile in Egyptian children and adolescents with COVID‐19 pneumonia: A multicenter study	13
Effectiveness of hypertonic saline nebulization in airway clearance in children with non‐cystic fibrosis bronchiectasis: A randomized control trial	13
Impact of elexacaftor/tezacaftor/ivacaftor on vitamin D absorption in cystic fibrosis patients	13
Evaluating FEV1 decline in diagnosis and management of pulmonary exacerbations in children with cystic fibrosis	13
Delayed season's onset and reduction of incidence of bronchiolitis during COVID‐19 pandemic	13
Phenotypic variance in pediatric obstructive sleep apnea	13
Thoracic CTA in infants and young children: Image quality of dual‐source CT (DSCT) with high‐pitch spiral scan mode (turbo flash spiral mode) with or without general anesthesia with free‐breathing tec	13
Viruses and Mycoplasma pneumoniae are the main etiological agents of community‐acquired pneumonia in hospitalized pediatric patients in Spain	13
Lung perfusion assessment in children with long‐COVID: A pilot study	12
The return of RSV during the COVID‐19 pandemic	12
Thoracoscopy versus thoracotomy for congenital lung malformations treatment: A single center experience	12
Incidence, predictors of success and outcome of LISA in very preterm infants	12
Chronic wet cough in Australian children: Societal costs and quality of life	12
“You're on mute!” Does pediatric CF home spirometry require physiologist supervision?	12
Pulmonary embolism in pediatric age: A retrospective study from a tertiary center	12
Lung ultrasound in Italian neonatal intensive care units: A national survey	12
The effect of telerehabilitation on quality of life, anxiety, and depression in children with cystic fibrosis and caregivers: A single‐blind randomized trial	12
COVID‐19: Impact, experiences, and support needs of children and young adults with cystic fibrosis and parents	12
A breakthrough effect of gene replacement therapy on respiratory outcomes in children with spinal muscular atrophy	12
Maternal iron status during early pregnancy and school‐age, lung function, asthma, and allergy: The Generation R Study	12
Life course body mass index through childhood and young adulthood and risks of asthma and pulmonary function impairment	12
Pulmonary manifestations of immune dysregulation in CTLA‐4 haploinsufficiency and LRBA deficiency	12
Detection of bacterial pathogens using home oropharyngeal swab collection in children with cystic fibrosis	12
Understanding the environmental factors related to the decrease in Pediatric Emergency Department referrals for acute asthma during the SARS‐CoV‐2 pandemic	12
Patient and family perspectives regarding the use of telehealth for cystic fibrosis care	12
Impulse oscillometry in preschool children with persistent asthma can predict spirometry at school age	12
Impact of elexacaftor/tezacaftor/ivacaftor on bacterial cultures from people with cystic fibrosis	12
Gradual increase in sweat chloride concentration is associated with a higher risk of CRMS/CFSPID to CF reclassification	12
Cardiorespiratory effects of NIV‐NAVA, NIPPV, and NCPAP shortly after extubation in extremely preterm infants: A randomized crossover trial	12
Food insecurity and mental health during the COVID‐19 pandemic in cystic fibrosis households	11
Real‐world feasibility of short‐term, unsupervised home spirometry in CF	11
“New Trach Mom Here…”: A qualitative study of internet‐based resources by caregivers of children with tracheostomy	11
How many billions is enough? Prioritizing profits over patients with cystic fibrosis	11
An algorithm combining procalcitonin and lung ultrasound improves the diagnosis of bacterial pneumonia in critically ill children: The PROLUSP study, a randomized clinical trial	11
Retrospective analysis of inpatient polysomnogram characteristics and discharge outcomes in infants with bronchopulmonary dysplasia requiring home oxygen therapy	11
Early lung ultrasound score to predict noninvasive ventilation needing in neonates from 33 weeks of gestational age: A multicentric study	11
Noninvasive high‐frequency oscillatory ventilation versus nasal intermittent positive pressure ventilation for preterm infants as an extubation support: A systematic review and meta‐analysis	11
The impact of elexacaftor/tezacaftor/ivacaftor on body composition in a small cohort of youth with cystic fibrosis	11
Updates in idiopathic pulmonary hemosiderosis in 2022: A state of the art review	11
The ISPAT project: Implementation of a standardized training program for caregivers of children with tracheostomy	11
Ultrasound of pneumothorax in neonates: Diagnostic value of the anterior transverse plane and of mirrored ribs	11
Feasibility and efficacy of active remote monitoring of home ventilation in pediatrics	11
Effect of Trikafta on bone density, body composition and exercise capacity in CF: A pilot study	11
Early volume targeted ventilation in preterm infants born at 22–25 weeks of gestational age	11
A pediatric high‐flow nasal cannula protocol standardizes initial flow and expedites weaning	11

A child with SARS‐CoV2‐induced croup	11
Development and technical validation of a smartphone‐based pediatric cough detection algorithm	11
Vascular and pulmonary comorbidities in children with congenital EA/TEF	11
Asthma and COVID‐19: An early inpatient and outpatient experience at a US children's hospital	11
Fatal SARS‐CoV‐2 Omicron variant in a young infant: Autopsy findings	10
Understanding the expanding role of pharmacy services in outpatient cystic fibrosis care	10
Obesity is a risk factor for decrease in lung function after COVID‐19 infection in children with asthma	10
Primary ciliary dyskinesia due to CCNO mutations—A genotype‐phenotype correlation contribution	10
Early childhood developmental skills of children with tracheostomies and ventilators recently discharged home	10
Autophagy‐related 5 gene mRNA expression and ATG5 rs510432 polymorphism in children with bronchial asthma	10
Lung transplantation as an intervention for pediatric pulmonary hypertension	10
Environmental radon and childhood asthma	10
Genetic counseling access for parents of newborns who screen positive for cystic fibrosis: Consensus guidelines	10
The predictive value of impulse oscillometry for asthma exacerbations in childhood: A systematic review and meta‐analyses	10
Pediatric pneumonia (PedPne) lung ultrasound score and inflammatory markers: A pilot study	10
Clinical validation of a mandibular movement signal based system for the diagnosis of pediatric sleep apnea	10
Respiratory distress syndrome in preterm infants of less than 32 weeks: What difference does giving 100 or 200 mg/kg of exogenous surfactant make?	10
Tracing the path of inhaled nitric oxide: Biological consequences of protein nitrosylation	10
Pediatric respiratory admissions and related viral infections during the COVID‐19 pandemic	10
Risk factors for recurrent pulmonary exacerbation in idiopathic pulmonary hemosiderosis	10
Sleep‐disordered breathing, respiratory patterns during wakefulness and functional capacity in pediatric patients with rapid‐onset obesity with hypothalamic dysfunction, hypoventilation and autonomic	10
Cardiovascular impact and sequelae of bronchopulmonary dysplasia	10
Prematurity, the diagnosis of bronchopulmonary dysplasia, and maturation of ventilatory control	10
Outcomes of repeat sweat testing in cystic fibrosis newborn screen positive infants	10
Transcutaneous monitoring of diaphragm activity as a measure of work of breathing in preterm infants	10
Impact of obstructive sleep apnea on assisted ventilation in children with asthma exacerbation	10
Early‐onset, fatal interstitial lung disease in STAT3 gain‐of‐function patients	10
Intra‐tracheal surfactant/budesonide versus surfactant alone: Comparison of two consecutive cohorts of extremely preterm infants	10
Effects of early vitamin D supplementation on the prevention of bronchopulmonary dysplasia in preterm infants	10
Interventional therapy via flexible bronchoscopy in the management of foreign body‐related occlusive endobronchial granulation tissue formation in children	10
Efficacy and safety of surfactant administration via thin catheter in preterm infants with neonatal respiratory distress syndrome: A systematic review and meta‐analysis	10
Ductus arteriosus flow predicts outcome in neonates with congenital diaphragmatic hernia	10
Cost‐utility of as‐needed combination low‐dose budesonide‐formoterol in adolescents mild asthma	10
Sociodemographic factors associated with tracheostomy and mortality in bronchopulmonary dysplasia	10
Childhood bronchiolitis obliterans in Hong Kong‐case series over a 20‐year period	10
Nonmyeloablative hematopoietic stem cell transplantation in a patient with hereditary pulmonary alveolar proteinosis	9
Tracheostomy prediction model in neonatal bronchopulmonary dysplasia via lung and airway MRI	9
Interobserver agreement in interpretation of chest radiographs for pediatric community acquired pneumonia: Findings of the pedCAPNETZ‐cohort	9
Noncystic fibrosis bronchiectasis in children and adolescents: Follow‐up over a decade	9
Association of vitamin D status at birth with pulmonary disease morbidity in very preterm infants	9
Pulmonary hypertension is an important co‐morbidity in developmental lung diseases of infancy: Bronchopulmonary dysplasia and congenital diaphragmatic hernia	9
Risk factors for obstructive sleep apnea in cystic fibrosis	9
The asthma predictive index as a surrogate diagnostic tool in preschoolers: Analysis of a longitudinal birth cohort	9
Twenty‐four‐hour pretreatment with low dose (0.25 mg/kg/dose) versus high dose (0.5 mg/kg/dose) dexamethasone in reducing the risk of postextubation airway obstruction in children: A randomized open‐l	9
Long‐term predictors of loss of asthma control in school‐aged well‐controlled children with mild to moderate asthma: A 5‐year follow‐up	9
Chronic respiratory failure in bronchopulmonary dysplasia	9
Elexacaftor/tezacaftor/ivacaftor in children aged 6–11 years with cystic fibrosis, at least one F508DEL allele, and advanced lung disease: A 24‐week observational study	9
Pulmonary alveolar proteinosis due to heterozygous mutation in OAS1: Whole lung lavages for long‐term bridging to hematopoietic stem cell transplantation	9
The clinical management of extralobar pulmonary sequestration in children	9
Transbronchial lung cryobiopsy for diffuse lung diseases in children: A case series	9
Sedation for bronchoscopy in children: A prospective randomized double‐blinded trial	9
Pulmonary sequelae of pediatric patients after discharge for COVID‐19: An observational study	9
Nutritional status, swallowing disorders, and respiratory prognosis in adult Duchenne muscular dystrophy patients	9
The burden of sleep disordered breathing in children with sickle cell disease	9
Bronchiolitis phenotypes identified by latent class analysis may influence the occurrence of respiratory sequelae	9
Twelve years of progressive Mycobacterium abscessus lung disease in CF—Response to Trikafta	9
Quantitative assessment of COVID‐19 pneumonia in neonates using lung ultrasound score	9
Association between idiopathic pulmonary hemosiderosis and celiac disease in pediatric patients: A scoping review of the literature over the past 50 years	9
Benefit of pulmonary subspecialty care for children with sickle cell disease and asthma	9
Poor early childhood growth is associated with impaired lung function: Evidence from a Ghanaian pregnancy cohort	9
Ten rules for ordering chest CTs	9
Intensive care management of right ventricular failure and pulmonary hypertension crises	9
Carbon dioxide monitoring in the newborn infant	9
Feasibility of nasal NO screening in healthy newborns	9
Disparities in cystic fibrosis survival in Mexico: Impact of socioeconomic status	9
Effect of lockdowns on the epidemiology of pediatric respiratory disease—A retrospective analysis of the 2021 summer epidemic	9
Change in CF care during COVID‐19 pandemic: Single‐center experience in a middle‐income setting	9
Vitamins A, D, E status as related to supplementation and lung disease markers in young children with cystic fibrosis	9
Healthcare resource utilization and costs among children with cystic fibrosis in the United States	9
Pediatric respiratory hospitalizations in small for gestational age neonates born at term	9
Zinc status and growth in infants and young children with cystic fibrosis	9
Unforeseen changes in seasonality of pediatric respiratory illnesses during the first COVID‐19 pandemic year	9
High‐frequency oscillatory ventilation in children: A systematic review and meta‐analysis	8
EVALI versus MIS‐C, one more overlapping diagnosis to consider	8
Respiratory setback associated with extubation failure in extremely preterm infants	8
Long‐term course of bronchial inflammation and pulmonary function testing in children with postinfectious bronchiolitis obliterans	8
Opportunity for pharmacogenomic testing in patients with cystic fibrosis	8
Patient characteristics associated with complications during neonatal intubations	8
Chronic tracheostomy care of ventilator‐dependent and ‐independent children: Clinical practice patterns of pediatric respirologists in a publicly funded (Canadian) healthcare system	8
Positive airway pressure for the treatment of the childhood obstructive sleep apnea syndrome	8
Dupilumab in children with moderate‐to‐severe asthma: A cost utility analysis	8
Ultrasound performed shortly after birth can predict the respiratory support needs of late preterm and term infants: A diagnostic accuracy study	8
Safety and tolerability of combination therapy with ambrisentan and tadalafil for the treatment of pulmonary arterial hypertension in children: Real‐world experience	8
Pulmonary eosinophilic vasculitis with granulomas and benralizumab in children	8
Laryngeal sensation and its association with aspiration and cough in children with neurological impairment	8
Infant RSV immunoprophylaxis changes nasal epithelial DNA methylation at 6 years of age	8
Cepacia syndrome in cystic fibrosis: A systematic review of the literature and possible new perspectives in treatment	8
Comorbidity and long‐term clinical outcome of laryngotracheal clefts types III and IV: Systematic analysis of new cases	8
Longitudinal changes in lung function in very prematurely born young people receiving high‐frequency oscillation or conventional ventilation from birth	8
Effectiveness and safety of early combined utilization of budesonide and surfactant by airway for bronchopulmonary dysplasia prevention in premature infants with RDS: A meta‐analysis	8
Pediatric MR lung imaging with 3D ultrashort‐TE in free breathing: Are we past the conventional T2 sequence?	8
Tough transitions: Family caregiver experiences with a pediatric long‐term ventilation discharge pathway	8
A statement on the current status and future needs of the pediatric pulmonology workforce: Pipeline Workgroup	8
Central breathing abnormalities in children with trisomy 21: Effect of age, sex, and concomitant OSA	8
E‐cigarette and vaping product use‐associated lung injury in the pediatric population: A critical review of the current literature	8